Type of analysis | Categories of HIV-1 positive blood donors | Median duration in months (95% CI) | P value | |||
Over all | i vs ii | iii vs iv | i vs iii | |||
Symptom free duration* (n = 108) | i. Fe pos PT (n - 38) | 30 (26,32) | <0.001 | <0.001 | <0.001 | <0.001 |
ii. Fe pos Non-PT (n = 16) | 67 (60,71) | |||||
iii. Fe neg PT (n - 10) | 47 (42,49) | |||||
iv. Fe neg Non-PT (n = 44) | 80 (72,87) | |||||
Survival duration (n = 96) | i. Fe pos PT (n = 38) | 47 (42,48) | <0.001 | <0.001 | <0.001 | <0.001 |
ii. Fe pos Non-PT (n = 16) | 95 (90,100) | |||||
iii. Fe neg PT (n = 10) | 71 (65,76) | |||||
iv. Fe neg Non-PT (n = 32)** | 107 (102,112) |